Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97847602 | 9784760 | 2 | F | 20090907 | 20151204 | 20131227 | 20160902 | EXP | GB-ROCHE-1324612 | ROCHE | 75.00 | YR | M | Y | 0.00000 | 20160902 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97847602 | 9784760 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | ON DAYS 1-21 | U | 20896 | BID | ||||||||
| 97847602 | 9784760 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 97847602 | 9784760 | 3 | SS | SARGRAMOSTIM | SARGRAMOSTIM | 1 | Intradermal | U | 0 | ||||||||||
| 97847602 | 9784760 | 4 | C | PYRIDOXINE | PYRIDOXINE | 1 | 0 | ||||||||||||
| 97847602 | 9784760 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 97847602 | 9784760 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 97847602 | 9784760 | 7 | C | EUMOVATE CREAM | 2 | 0 | |||||||||||||
| 97847602 | 9784760 | 8 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 0 | ||||||||||||
| 97847602 | 9784760 | 9 | C | LACTULOSE. | LACTULOSE | 1 | Unknown | 0 | |||||||||||
| 97847602 | 9784760 | 10 | C | COLESTYRAMIN | 2 | 0 | |||||||||||||
| 97847602 | 9784760 | 11 | C | GAVISCON (ALGINIC ACID) | 2 | 0 | |||||||||||||
| 97847602 | 9784760 | 12 | C | DICLOFENAC | DICLOFENAC | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97847602 | 9784760 | 1 | Pancreatic carcinoma |
| 97847602 | 9784760 | 2 | Pancreatic carcinoma |
| 97847602 | 9784760 | 3 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97847602 | 9784760 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97847602 | 9784760 | Bile duct obstruction | |
| 97847602 | 9784760 | Biliary sepsis | |
| 97847602 | 9784760 | Device occlusion | |
| 97847602 | 9784760 | Device related infection | |
| 97847602 | 9784760 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |